Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.780
-0.080 (-2.80%)
At close: Oct 6, 2026, 4:00 PM EDT
2.820
+0.040 (1.44%)
After-hours: Oct 6, 2026, 4:03 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $290.71 million as of October 6, 2026. Its market cap has decreased by -30.26% in one year.
Market Cap
290.71M
Enterprise Value
139.40M
1-Year Change
-30.26%
Ranking
Category
Stock Price
$2.78
ChartMarket Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $290.71M, an increase of 156.40%. That is a compound annual growth rate of 15.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 290.71M | -10.85% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cabaletta Bio | 339.09M |
| Artiva Biotherapeutics | 333.92M |
| Scribe Therapeutics | 317.86M |
| Indaptus Therapeutics | 317.12M |
| Benitec Biopharma | 313.25M |
| BridgeBio Oncology Therapeutics | 311.88M |
| Lexeo Therapeutics | 289.61M |
| Abeona Therapeutics | 287.64M |